effect overlay
activetrials
Stroke
Stroke
EXTEND-AGNES TNK

Post-thrombectomy intra-arterial tenecteplase for Acute manaGement of Non-retrievable thrombus and no-reflow in Emergent Stroke

HREC: 2023.138
Principal Investigator: Prof Bruce Campbell
Coordinator contact: David Jackson
Funding: Non-Commercial
Stroke
Stroke
FRONTIER-AP

Randomized controlled trial of endovascular versus standard medical therapy for stroke with medium sized vessel occlusion

HREC: 2022.308
Principal Investigator: Prof Bernard Yan
Coordinator contact: Amy McDonald
Funding: Non-Commercial
Stroke
Stroke
Coagulation in Vasculopathy and COVID-19

Coagulation in Vasculopathy and COVID-19

HREC: 2020.191
Principal Investigator: Prof Bruce Campbell
Coordinator contact:
Funding: Non-Commercial
Stroke
Stroke
Cognitive outcomes after cerebral ischaemia

Cognitive outcomes after cerebral ischaemia

HREC: 2017.148
Principal Investigator: A/Prof Nawaf Yassi
Coordinator contact:
Funding: Non-Commercial
Stroke
Stroke
ARG 007

A Phase II, Multicenter, Double Blinded, Randomized, Placebo Controlled, Parallel-Group, Single-Dose Study to Determine the Safety, Preliminary Efficacy,and Pharmacokinetics of ARG 007 in Acute Ischemic Stroke Patients
 

HREC: 2023.189
Principal Investigator: Prof Bruce Campbell
Coordinator contact: Christine Shin
Funding: Commercial